These medications, including semaglutide and liraglutide, have demonstrated substantial efficacy in promoting weight loss and improving glycemic control, which can help mitigate related health issues such as cardiovascular disease, obesity, and type 2 diabetes
Then verify once more
Clinical trial data from the STEP program showed that semaglutide 2.4mg weekly produced average weight loss of 14.9% of body weight over 68 weeks, compared to tirzepatide at 15mg which achieved approximately 22.5% in the SURMOUNT trials
Mounjaro Download our GLP-1 app to Turn Your Weight Loss Journey into Your Favorite Game Is Tirzepatide the Same as Mounjaro
Since ADA (American Diabetes Association) and FDA confirmed that apart from metformin in Type 2 diabetes management, Glucagon-like peptide-1 analogues give favourable results, especially in contraindication and metformin intolerance patients, so the use of GLP-1 agonists is highly preferred treatment in lower serum glucose levels or hypoglycemia
This definitely supports Kariya Pharmaceuticals hypothesis around the importance of brain-penetrance when treating CNS conditions